AtriCure (ATRC) Reiterated at Market Outperform by Citizens Ahead of Q4 Earnings
Tweet Send to a Friend
Citizens analyst Daniel Stauder reiterated a Market Outperform rating and $60.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
